Santa Cruz do Sul

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Kidney cancer

Closed trials

• Completed

  A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

  NCT04540705· Phase 1· Bristol-Myers Squibb· Source